PATENT CASE OF THE WEEK -
JTEKT Corporation v. GKN Automotive Ltd., Appeal No. 2017-1828 (Fed. Cir. Aug. 3, 2018)
The Federal Circuit dismissed an appeal from an inter partes review, holding that, although JTEKT...more
8/8/2018
/ Appeals ,
Article III ,
Design Patent ,
Dismissals ,
Injury-in-Fact ,
Inter Partes Review (IPR) Proceeding ,
Judgment on the Pleadings ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prosecution History Estoppel ,
Remand ,
Reversal ,
SAS Institute Inc. v Iancu ,
Standing ,
USPTO
Aatrix Software, Inc. v. Green Shades Software, Inc., Appeal No. 2017-1452 (Fed. Cir. May 31, 2018) and Berkheimer v. HP Inc., Appeal No. 2017-1437 (Fed. Cir. May 31, 2018) -
In these two, published, precedential orders...more
6/5/2018
/ Abstract Ideas ,
Amended Complaints ,
Anticipatory Reference ,
Denial of Rehearing ,
En Banc Review ,
Federal Rule 12(b)(6) ,
Indefiniteness ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Inventive Concept Test ,
Obviousness ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Question of Law ,
Remand ,
Reversal ,
Section 101 ,
Summary Judgment ,
Triable Issue of Fact
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., Appeal Nos. 2016-2616, -2656 (Fed. Cir. May 16, 2018) -
In an appeal from a inter partes review, the Federal Circuit reviewed a PTAB obviousness...more
5/22/2018
/ Burden of Proof ,
Claim Construction ,
Claim Limitations ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Patents ,
Prior Art ,
Section 101 ,
Venue ,
Writ of Mandamus
In an ANDA applicant’s appeal from a bench trial judgment of validity and infringement, the Court affirmed the district court’s judgment on all counts. The case presented unusual procedural circumstances in a Hatch-Waxman...more
4/17/2018
/ Abbreviated New Drug Application (ANDA) ,
Failure To State A Claim ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Induced Infringement ,
Off-Label Use ,
Orange Book ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patent-in-Suit ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs
Berkheimer v. HP Inc., Appeal No. 2017-1437 (Fed. Cir. Feb. 8, 2018) -
In Berkheimer v. HP Inc., the Federal Circuit reviewed the District Court’s summary judgment finding that certain claims of a patent were invalid as...more
2/13/2018
/ AbbVie ,
Abstract Ideas ,
Antitrust Violations ,
Appeals ,
CLS Bank v Alice Corp ,
Contract Disputes ,
Contract Interpretation ,
Declaratory Judgments ,
Discovery Violations ,
Expert Testimony ,
Fraud ,
Hatch-Waxman ,
Hospira ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Jurisdiction ,
License Agreements ,
Licensees ,
Merck ,
Misrepresentation ,
Motivation to Combine ,
Motor Vehicles ,
Nonobvious ,
Obviousness ,
On-Sale Bar ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Prior Art ,
Sales & Distribution Agreements ,
Section 101 ,
Substantial Evidence ,
Summary Judgment ,
Walker Process Claims ,
Wrongful Termination